Related references
Note: Only part of the references are listed.Polymeric biocompatible iron oxide nanoparticles labeled with peptides for imaging in ovarian cancer
Deepshikha Shahdeo et al.
BIOSCIENCE REPORTS (2022)
Constitutional PIGA mutations cause a novel subtype of hemochromatosis in patients with neurologic dysfunction
Lena Muckenthaler et al.
BLOOD (2022)
Hemochromatosis classification: update and recommendations by the BIOIRON Society
Domenico Girelli et al.
BLOOD (2022)
Iron- and erythropoietin-resistant anemia in a spontaneous breast cancer mouse model
Nuria Fabregas Bregolat et al.
HAEMATOLOGICA (2022)
Sickle Cell Disease: A Review
Patricia L. Kavanagh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
Myelodysplastic syndromes with ring sideroblasts (MDS-RS) and MDS/myeloproliferative neoplasm with RS and thrombocytosis (MDS/MPN-RS-T) - 2021 update on diagnosis, risk-stratification, and management
Mrinal M. Patnaik et al.
AMERICAN JOURNAL OF HEMATOLOGY (2021)
Revisiting the non-transfusion-dependent (NTDT) vs. transfusion-dependent (TDT) thalassemia classification 10 years later
Khaled M. Musallam et al.
AMERICAN JOURNAL OF HEMATOLOGY (2021)
Iron deficiency
Sant-Rayn Pasricha et al.
LANCET (2021)
Increase of plasma erythroferrone levels during high-altitude exposure: A sub-analysis of the TOP OF HOMe study
Insa E. Emrich et al.
AMERICAN JOURNAL OF HEMATOLOGY (2021)
Mitochondrial iron metabolism and its role in diseases
Jiayin Gao et al.
CLINICA CHIMICA ACTA (2021)
β-Thalassemias
Ali T. Taher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Newer formulations of intravenous iron: a review of their chemistry and key safety aspects - hypersensitivity, hypophosphatemia, and cardiovascular safety
Irina Blumenstein et al.
EXPERT OPINION ON DRUG SAFETY (2021)
Intravenous Iron-Induced Hypophosphatemia: An Emerging Syndrome
John A. Glaspy et al.
ADVANCES IN THERAPY (2021)
Concise review: how do red blood cells born, live, and die?
J. L. Vives Corrons et al.
ANNALS OF HEMATOLOGY (2021)
Macrophage Polarization States in the Tumor Microenvironment
Ava J. Boutilier et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
The Macrophage Iron Signature in Health and Disease
Christina Mertens et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Mendelian inheritance of anemia due to disturb e d iron homeostasis
Clara Camaschella et al.
SEMINARS IN HEMATOLOGY (2021)
The role of iron repletion in adult iron deficiency anemia and other diseases
Benjamin Elstrott et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2020)
Iron metabolism and iron disorders revisited in the hepcidin era
Clara Camaschella et al.
HAEMATOLOGICA (2020)
Oral ferroportin inhibitor ameliorates ineffective erythropoiesis in a model of β-thalassemia
Vania Manolova et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Iron Metabolism at the Interface between Host and Pathogen: From Nutritional Immunity to Antibacterial Development
Marialaura Marchetti et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Basics and principles of cellular and systemic iron homeostasis
Angeliki Katsarou et al.
MOLECULAR ASPECTS OF MEDICINE (2020)
Regulation of iron homeostasis: Lessons from mouse models
Sandro Altamura et al.
MOLECULAR ASPECTS OF MEDICINE (2020)
TLR4 Signaling by Heme and the Role of Heme-Binding Blood Proteins
Sabina Janciauskiene et al.
FRONTIERS IN IMMUNOLOGY (2020)
Role of iron metabolism in heart failure: From iron deficiency to iron overload
Hao Zhang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2019)
Targeting the hepcidin-ferroportin pathway in anaemia of chronic kidney disease
Matthew Sheetz et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Transferrin receptor 1 overexpression is associated with tumour de-differentiation and acts as a potential prognostic indicator of hepatocellular carcinoma
Makiko Adachi et al.
HISTOPATHOLOGY (2019)
The Tumor Microenvironment Innately Modulates Cancer Progression
Dominique C. Hinshaw et al.
CANCER RESEARCH (2019)
Macrophages and Metabolism in the Tumor Microenvironment
Ilio Vitale et al.
CELL METABOLISM (2019)
TLR4 activation alters labile heme levels to regulate BACH1 and heme oxygenase-1 expression in macrophages
Kritika Sudan et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Anemia of Inflammation
Tomas Ganz
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Iron accumulation in tumor-associated macrophages marks an improved overall survival in patients with lung adenocarcinoma
Carl Maximilian Thielmann et al.
SCIENTIFIC REPORTS (2019)
Iron metabolism under conditions of ineffective erythropoiesis in β-thalassemia
Stefano Rivella
BLOOD (2019)
Non-transferrin-bound iron transporters
Mitchell D. Knutson
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Hepatic hepcidin/intestinal HIF-2α axis maintains iron absorption during iron deficiency and overload
Andrew J. Schwartz et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
SLN124, a GalNAc-siRNA Conjugate Targeting TMPRSS6, Efficiently Prevents Iron Overload in Hereditary Haemochromatosis Type 1
Sandro Altamura et al.
HEMASPHERE (2019)
Macrophage-derived lipocalin-2 transports iron in the tumor microenvironment
Christina Mertens et al.
ONCOIMMUNOLOGY (2018)
Congenital sideroblastic anemia: Advances in gene mutations and pathophysiology
Zhangbiao Long et al.
GENE (2018)
Molecular Basis and Genetic Modifiers of Thalassemia
Sachith Mettananda et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2018)
Evaluation of Hemolysis as a Severe Feature of Preeclampsia
Richard M. Burwick et al.
HYPERTENSION (2018)
Mechanisms of Hemolysis During Sepsis
Katharina Effenberger-Neidnicht et al.
INFLAMMATION (2018)
The role of HFE genotype in macrophage phenotype
Anne M. Nixon et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Haemochromatosis
Pierre Brissot et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Diagnosis and Management of Genetic Iron Overload Disorders
William C. Palmer et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2018)
E4BP4 promotes thyroid cancer proliferation by modulating iron homeostasis through repression of hepcidin
Qinyi Zhou et al.
CELL DEATH & DISEASE (2018)
Metastatic growth instructed by neutrophil-derived transferrin
Wei Liang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Iron as a Therapeutic Target in HFE-Related Hemochromatosis: Usual and Novel Aspects
Olivier Loreal et al.
PHARMACEUTICALS (2018)
Beyond transfusion therapy: new therapies in thalassemia including drugs, alternate donor transplant, and gene therapy
John Porter
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2018)
Angiocrine Bmp2 signaling in murine liver controls normal iron homeostasis
Philipp-Sebastian Koch et al.
BLOOD (2017)
Gender differences in liver disease and the drug-dose gender gap
Elena Buzzetti et al.
PHARMACOLOGICAL RESEARCH (2017)
Transferrin receptor 1 upregulation in primary tumor and downregulation in benign kidney is associated with progression and mortality in renal cell carcinoma patients
Christopher J. Greene et al.
ONCOTARGET (2017)
Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials
Nicole U. Stoffel et al.
LANCET HAEMATOLOGY (2017)
Bone morphogenetic protein 2 controls iron homeostasis in mice independent of Bmp6
Susanna Canali et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management
Maria Domenica Cappellini et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Iron-induced hypophosphatemia: an emerging complication
Heinz Zoller et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2017)
A Red Carpet for Iron Metabolism
Martina U. Muckenthaler et al.
CELL (2017)
Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease
Francesca Vinchi et al.
BLOOD (2016)
Local iron homeostasis in the breast ductal carcinoma microenvironment
Oriana Marques et al.
BMC CANCER (2016)
Effects of renal impairment on the pharmacokinetics of orally administered deferiprone
Caroline Fradette et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
How we manage patients with hereditary haemochromatosis
Eva Rombout-Sestrienkova et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
New insights into transfusion-related iron toxicity: Implications for the oncologist
John B. Porter et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
The Global Burden of Anemia
Nicholas J. Kassebaum
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2016)
Molecular pathogenesis and clinical consequences of iron overload in liver cirrhosis
Katarzyna Sikorska et al.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2016)
Iron metabolism and related genetic diseases: A cleared land, keeping mysteries
Pierre Brissot et al.
JOURNAL OF HEPATOLOGY (2016)
Recent treatment guidelines for managing adult patients with sickle cell disease: challenges in access to care, social issues, and adherence
Patricia Adams-Graves et al.
EXPERT REVIEW OF HEMATOLOGY (2016)
The role of TMPRSS6 polymorphisms in iron deficiency anemia partially responsive to oral iron treatment
Erika Poggiali et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women
Diego Moretti et al.
BLOOD (2015)
Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of β-thalassemia
Leon Kautz et al.
BLOOD (2015)
Hepcidin Regulation in Prostate and Its Disruption in Prostate Cancer
Lia Tesfay et al.
CANCER RESEARCH (2015)
Iron Chelation in Thalassemia Major
Caterina Borgna-Pignatti et al.
CLINICAL THERAPEUTICS (2015)
Diagnosis and Management of Hereditary Hemochromatosis
Reena J. Salgia et al.
CLINICS IN LIVER DISEASE (2015)
Effect of oral liposomal iron versus intravenous iron for treatment of iron deficiency anaemia in CKD patients: a randomized trial
Antonio Pisani et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
A mouse model of anemia of inflammation: complex pathogenesis with partial dependence on hepcidin
Airie Kim et al.
BLOOD (2014)
HFE interacts with the BMP type I receptor ALK3 to regulate hepcidin expression
Xing-gang Wu et al.
BLOOD (2014)
Resistance of Ferroportin to Hepcidin Binding causes Exocrine Pancreatic Failure and Fatal Iron Overload
Sandro Altamura et al.
CELL METABOLISM (2014)
Sideroblastic Anemia Diagnosis and Management
Sylvia S. Bottomley et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2014)
Iron deficiency in chronic heart failure: An international pooled analysis
IJsbrand T. Klip et al.
AMERICAN HEART JOURNAL (2013)
The gut in iron homeostasis: role of HIF-2 under normal and pathological conditions
Maria Mastrogiannaki et al.
BLOOD (2013)
How I manage patients with atypical microcytic anaemia
Clara Camaschella
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Iron in Infection and Immunity
James E. Cassat et al.
CELL HOST & MICROBE (2013)
Iron refractory iron deficiency anemia
Luigia De Falco et al.
HAEMATOLOGICA (2013)
Reducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in mice
Shuling Guo et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Regulation of iron transport and the role of transferrin
Konstantinos Gkouvatsos et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
Non-transferrin bound iron: A key role in iron overload and iron toxicity
Pierre Brissot et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
Deferasirox reduces iron overload significantly in nontransfusion-dependent thalassemia: 1-year results from a prospective, randomized, double-blind, placebo-controlled study
Ali T. Taher et al.
BLOOD (2012)
Iron overload in non-transfusion-dependent thalassemia: a clinical perspective
Khaled M. Musallam et al.
BLOOD REVIEWS (2012)
Functional role of the putative iron ligands in the ferroxidase activity of recombinant human hephaestin
Ganna Vashchenko et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2012)
Regulation of cellular iron metabolism
Jian Wang et al.
BIOCHEMICAL JOURNAL (2011)
Iron regulatory protein-1 and-2: transcriptome-wide definition of binding mRNAs and shaping of the cellular proteome by iron regulatory proteins
Mayka Sanchez et al.
BLOOD (2011)
A novel N491S mutation in the human SLC11A2 gene impairs protein trafficking and in association with the G212V mutation leads to microcytic anemia and liver iron overload
Edouard Bardou-Jacquet et al.
BLOOD CELLS MOLECULES AND DISEASES (2011)
Iron Regulation of Hepcidin Despite Attenuated Smad1,5,8 Signaling in Mice Without Transferrin Receptor 2 or Hfe
Elena Corradini et al.
GASTROENTEROLOGY (2011)
Evidence for Distinct Pathways of Hepcidin Regulation by Acute and Chronic Iron Loading in Mice
Emilio Ramos et al.
HEPATOLOGY (2011)
Disordered Iron Homeostasis in Chronic Heart Failure Prevalence, Predictors, and Relation to Anemia, Exercise Capacity, and Survival
Darlington O. Okonko et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Combined iron chelation therapy
Renzo Galanello et al.
COOLEY'S ANEMIA: NINTH SYMPOSIUM (2010)
Hemoglobin and Heme Scavenger Receptors
Marianne Jensby Nielsen et al.
ANTIOXIDANTS & REDOX SIGNALING (2010)
Two to Tango: Regulation of Mammalian Iron Metabolism
Matthias W. Hentze et al.
CELL (2010)
Differential regulation of iron homeostasis during human macrophage polarized activation
Stefania Recalcati et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Hereditary Hemochromatosis: Pathogenesis, Diagnosis, and Treatment
Antonello Pietrangelo
GASTROENTEROLOGY (2010)
Ferroportin and Iron Regulation in Breast Cancer Progression and Prognosis
Zandra K. Pinnix et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Clinical Use of Intravenous Iron: Administration, Efficacy, and Safety
Michael Auerbach et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2010)
FGF23 Elevation and Hypophosphatemia after Intravenous Iron Polymaltose: A Prospective Study
Belinda J. Schouten et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Iron overload and toxicity: the hidden risk of multiple blood transfusions
A. Shander et al.
VOX SANGUINIS (2009)
Systemic Iron Homeostasis and the Iron-Responsive Element/Iron-Regulatory Protein (IRE/IRP) Regulatory Network
Martina U. Muckenthaler et al.
Annual Review of Nutrition (2008)
The Serine Protease Matriptase-2 (TMPRSS6) Inhibits Hepcidin Activation by Cleaving Membrane Hemojuvelin
Laura Silvestri et al.
CELL METABOLISM (2008)
Survival of red blood cells after transfusion: a comparison between red cells concentrates of different storage periods
Marleen Luten et al.
TRANSFUSION (2008)
Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin
Ivana De Domenico et al.
EMBO JOURNAL (2007)
Modulation of iron transport proteins in human colorectal carcinogenesis
M. J. Brookes et al.
GUT (2006)
Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major
C Borgna-Pignatti et al.
BLOOD (2006)
Oral chelators deferasirox and defefiprone for transfusional iron overload in thalassen a major: new data, new questions
EJ Neufeld
BLOOD (2006)
Microcytic anemia and hepatic iron overload in a child with compound heterozygous mutations in DMT1 (SCL11A2)
A Iolascon et al.
BLOOD (2006)
Identification of the receptor scavenging hemopexin-heme complexes
V Hvidberg et al.
BLOOD (2005)
Medical progress: Anemia of chronic disease
G Weiss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Balancing acts: Molecular control of mammalian iron metabolism
MW Hentze et al.
CELL (2004)
CD163: a regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response
SK Moestrup et al.
ANNALS OF MEDICINE (2004)
IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin
E Nemeth et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Role of deferiprone in chelation therapy for transfusional iron overload
AV Hoffbrand et al.
BLOOD (2003)
Sodium ferric gluconate complex in hemodialysis patients: Adverse reactions compared to placebo and iron dextran
B Michael et al.
KIDNEY INTERNATIONAL (2002)
Nature of nontransferrin-bound iron
RC Hider
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2002)
Hepcidin, a urinary antimicrobial peptide synthesized in the liver
CH Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Identification of the haemoglobin scavenger receptor
M Kristiansen et al.
NATURE (2001)
Share Paper
